RSP15 mutation results in loss of RPS15 function and impaired p53 stability, leading to inferior survival outcome in CLL patients with mutated RPS15 compared to their counterpart with wild-type RPS15 [78]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.